4
Changes in Ownership
Greenwich LifeSciences, Inc. Filed Acc 0001493152-23-001009
CEO and CFO bought 1,500 shares at $15.18 ($22,770)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Snehal CEO and CFO | 2023-01-06 | Purchase | +1,500 | $15.18 | $22,770 | 2,731,386 | D |
| Open-market purchases · 1,500 sh · avg $15.18 · $22,770 | |||||||
Loading xslF345X03/ownership.xml…